SIGY
SIGYN THERAPEUTICS INCstockOTC
EODNov 18, 2026
0.02755USD+2.416%(+0.00065)18,166
SIGY Financials
In Q3 FY 2025 (ended ), SIGYN THERAPEUTICS INC (SIGY) reported revenue of $0, net income of −$578.5K, operating cash flow of −$199.33K, and assets of $135.57K (filed ).
Loading financial statements…